Literature DB >> 35175537

Horseshoe hepatectomy : Another step pursuing the concept of parenchyma sparing major hepatectomies.

Guido Costa1,2, Guido Torzilli3,4, Martina Sorrentino1,2, Matteo Donadon1,2.   

Abstract

We describe a case of complex parenchyma-sparing hepatectomy for multiple bilobar colorectal liver metastases. A 66-years-old male, who previously received a diagnosis of a stenosing adenocarcinoma of the hepatic flexure and synchronous bilobar liver metastases, was referred to our hospital. At the time of the presentation of the disease, a contrast-enhanced CT scan showed 24 liver lesions, with a bilobar distribution and two major cluster of lesions in segment 6 and 7. After neoadjuvant chemotherapy, global partial response, with complete response for most lesions, was detected: seven lesions were visible after re-staging. Surgical strategy was planned by means of three-dimensional reconstruction and simulation software. A unique transection plane comprising partial resection of segments 2, 3, 4, 5 and 8 and complete resection of segments 6 and 7 was performed. Left, middle and right hepatic veins were exposed on the cut surface. Accurate preoperative planning and intraoperative ultrasound for resection guidance allowed us to follow complex transection planes and treat a patient with a high burden of bilobar deeply located disease in a parenchymal-sparing perspective.
© 2022. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Colorectal liver metastases; Intra-operative ultrasound; Liver surgery; Parenchymal-sparing liver surgery

Mesh:

Year:  2022        PMID: 35175537     DOI: 10.1007/s13304-022-01242-4

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  7 in total

1.  Parenchyma-sparing vessel-guided major hepatectomy: nonsense or new paradigm in liver surgery?

Authors:  G Torzilli
Journal:  Br J Surg       Date:  2021-03-12       Impact factor: 6.939

2.  Is Enhanced One-Stage Hepatectomy a Safe and Feasible Alternative to the Two-Stage Hepatectomy in the Setting of Multiple Bilobar Colorectal Liver Metastases? A Comparative Analysis between Two Pioneering Centers.

Authors:  Guido Torzilli; Luca Viganò; Matteo Cimino; Katsunori Imai; Eric Vibert; Matteo Donadon; Doaa Mansour; Denis Castaing; Ren Adam
Journal:  Dig Surg       Date:  2018-02-13       Impact factor: 2.588

3.  Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.

Authors:  Luca Viganò; Fabio Procopio; Matteo Maria Cimino; Matteo Donadon; Andrea Gatti; Guido Costa; Daniele Del Fabbro; Guido Torzilli
Journal:  Ann Surg Oncol       Date:  2015-12-29       Impact factor: 5.344

4.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

5.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

6.  One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach.

Authors:  Guido Torzilli; Fabio Procopio; Florin Botea; Matteo Marconi; Daniele Del Fabbro; Matteo Donadon; Angela Palmisano; Antonino Spinelli; Marco Montorsi
Journal:  Surgery       Date:  2009-07       Impact factor: 3.982

7.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.